Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sherwood Scientific Exhibits Solution for Enzyme-Based Diagnostic Testing in Remote Locations

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Sherwood Scientific Ltd will exhibit the CHROMA Model 260uv Programmable Colorimeter for the first time at MEDICA 2013.

The instrument allows users to conduct enzyme-based tests in challenging and remote locations without access to a laboratory. Also on display at MEDICA will be Sherwood Scientific’s magnetic susceptibility balance and the model 926S Chloride analyser, both valuable and established tools in clinical applications.

The Model 260uv Programmable Colorimeter’s ability to operate in the near UV region makes it ideal for enzyme-based clinical diagnostic tests. Until recently, it has been difficult to run these tests on cost-efficient instruments while in the field. The 260uv Colorimeter is rugged and portable, and can run using a variety of power sources, including a 12V car battery, making it a prime solution for use in field hospitals and remote locations. In addition, the system can store up to 100 methods, allowing the use of most commercially available test kits and user-generated reagents, further increasing the convenience of the whole system.

Sherwood Scientific will also showcase its unique benchtop magnetic susceptibility balance at MEDICA. This well-established product is suited for use when analysing iron-coated contrast agents, such as those used in magnetic resonance imaging, and ensuring their compliance in line with pharmacopoeia monographs. Visitors to the stand will also have the opportunity to explore the use of the model 926S Chloride Analyser, highly regarded in the diagnosis of cystic fibrosis for more than 15 years.

“We are very much looking forward to attending MEDICA 2013,” said Jon Copsey, Marketing Manager at Sherwood Scientific Ltd. “This will be Sherwood Scientific’s first time exhibiting at the show, and we are excited to demonstrate how our systems can benefit users in clinical areas. We know that working in this sector can produce some unique challenges, and are confident that visitors to the stand will come away with valuable solutions.”

Visitors to MEDICA 2013 (20 - 23 November 2013, Düsseldorf Fairgrounds, Germany) can find Sherwood Scientific at Hall 01/E07.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!